Amgen Inc (NASDAQ:AMGN) over-valued by 13%
Website | http://www.amgen.com |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $142,851,358,720 |
Beta | 0.735245 |
Average Volume | $2,810,847 |
Last Dividend | 6.72% |
Price on Dec 31, 2021 | $241.01 |
Autochartist™ Valuation | $209.08 |
Conclusion |
13% over-valued |
Download Report |